home / post-conference-perspectives / esmo-world-congress-on-gi-cancer-2023 August 7th 2023EP. 1: Health-Related Quality of Life Outcomes in Metastatic Colorectal Cancer: Takeaways from the SUNLIGHT ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus (Nasdaq: AGEN), a leading immuno-oncology company dedicated to developing innovative treatments for cancer and infectious diseases, today announced a data ...
I-Mab will present clinical updates on givastomig at the Jefferies Global Healthcare Conference and share new data at ESMO 2025. I-Mab, a U.S.-based biotech company specializing in precision ...
Despite significant progress in the screening, detection, and treatment of cancer, it remains the second leading cause of death in the United States, and 1 in 3 Americans will be diagnosed with the ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced ...
ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment ...
STOCKHOLM, April 29, 2024 /PRNewswire/ -- Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, ...
John L. Marshall M.D., explains the importance of in-person conferences and the future of AI in the field. John L. Marshall, MD: The sad thing about what we need to do next is we don’t even know what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results